Teresa Purzner
Assistant Professor, Queen's University
- Position
- Assistant Professor
- University
- Queen's University
- Country
- Canada
Papers
- Using Quality Function Deployment to Design an Image-Guided, Multibiopsy Tool for Neurosurgical Applications (2025). Operative Neurosurgery. DOI 10.1227/ons.0000000000001696
- Dexamethasone-Induced p57-Mediated Quiescence Drives Chemotherapy Resistance in Sonic Hedgehog Medulloblastoma (2025). bioRxiv (Cold Spring Harbor Laboratory). DOI 10.1101/2025.04.27.650711
- Ezh2 Delays Activation of Differentiation Genes During Normal Cerebellar Granule Neuron Development and in Medulloblastoma (2025). eLife. DOI 10.7554/elife.105339
- Adult isocitrate dehydrogenase–mutant brainstem glioma: illustrative case (2021). Journal of Neurosurgery Case Lessons. DOI 10.3171/case2078
- LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumors (2020). Journal of Chromatography B. DOI 10.1016/j.jchromb.2020.122254
- Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide (2019). Oncogene. DOI 10.1038/s41388-019-1077-y
- Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide (2019). Oncogene. DOI 10.1038/s41388-019-0927-y
- Drug development is no longer just for Big Pharma. Researchers at Bio-X explain (2018). DOI 10.64628/aai.gqehuwxt9
- Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma (2018). Science Signaling. DOI 10.1126/scisignal.aau5147
- Abstract LB-322: Casein kinase 2 is a major regulator of medulloblastoma growth (2018). Cancer Research. DOI 10.1158/1538-7445.am2018-lb-322
Showing 10 of 16 papers.